173 related articles for article (PubMed ID: 8820101)
1. Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody.
Itabe H; Yamamoto H; Imanaka T; Shimamura K; Uchiyama H; Kimura J; Sanaka T; Hata Y; Takano T
J Lipid Res; 1996 Jan; 37(1):45-53. PubMed ID: 8820101
[TBL] [Abstract][Full Text] [Related]
2. Oxidized phosphatidylcholines that modify proteins. Analysis by monoclonal antibody against oxidized low density lipoprotein.
Itabe H; Yamamoto H; Suzuki M; Kawai Y; Nakagawa Y; Suzuki A; Imanaka T; Takano T
J Biol Chem; 1996 Dec; 271(52):33208-17. PubMed ID: 8969177
[TBL] [Abstract][Full Text] [Related]
3. Lysosomal accumulation of oxidized phosphatidylcholine-apolipoprotein B complex in macrophages: intracellular fate of oxidized low density lipoprotein.
Itabe H; Suzuki K; Tsukamoto Y; Komatsu R; Ueda M; Mori M; Higashi Y; Takano T
Biochim Biophys Acta; 2000 Sep; 1487(2-3):233-45. PubMed ID: 11018475
[TBL] [Abstract][Full Text] [Related]
4. Detection of oxidized low-density lipoproteins in gingival crevicular fluid from dental patients.
Sakiyama Y; Kato R; Inoue S; Suzuki K; Itabe H; Yamamoto M
J Periodontal Res; 2010 Apr; 45(2):216-22. PubMed ID: 19778326
[TBL] [Abstract][Full Text] [Related]
5. [Atherosclerosis and sensitive determination of oxidized LDL using monoclonal antibody].
Itabe H
Yakugaku Zasshi; 2002 Oct; 122(10):745-53. PubMed ID: 12400156
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides.
Itabe H; Takeshima E; Iwasaki H; Kimura J; Yoshida Y; Imanaka T; Takano T
J Biol Chem; 1994 May; 269(21):15274-9. PubMed ID: 8195164
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques.
Imanaga Y; Sakata N; Takebayashi S; Matsunaga A; Sasaki J; Arakawa K; Nagai R; Horiuchi S; Itabe H; Takano T
Atherosclerosis; 2000 Jun; 150(2):343-55. PubMed ID: 10856526
[TBL] [Abstract][Full Text] [Related]
8. Time course-changes in phosphatidylcholine profile during oxidative modification of low-density lipoprotein.
Sasabe N; Keyamura Y; Obama T; Inoue N; Masuko Y; Igarashi Y; Aiuchi T; Kato R; Yamaguchi T; Kuwata H; Iwamoto S; Miyazaki A; Hara S; Yoshikawa T; Itabe H
Lipids Health Dis; 2014 Mar; 13():48. PubMed ID: 24625108
[TBL] [Abstract][Full Text] [Related]
9. Oxidized low-density lipoproteins: what is understood and what remains to be clarified.
Itabe H
Biol Pharm Bull; 2003 Jan; 26(1):1-9. PubMed ID: 12520163
[TBL] [Abstract][Full Text] [Related]
10. Simple and practical sandwich-type enzyme immunoassay for human oxidatively modified low density lipoprotein using antioxidized phosphatidylcholine monoclonal antibody and antihuman apolipoprotein-B antibody.
Kohno H; Sueshige N; Oguri K; Izumidate H; Masunari T; Kawamura M; Itabe H; Takano T; Hasegawa A; Nagai R
Clin Biochem; 2000 Jun; 33(4):243-53. PubMed ID: 10936581
[TBL] [Abstract][Full Text] [Related]
11. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit.
Boyd HC; Gown AM; Wolfbauer G; Chait A
Am J Pathol; 1989 Nov; 135(5):815-25. PubMed ID: 2683796
[TBL] [Abstract][Full Text] [Related]
12. Immunoreactivity of apolipoprotein B-100 in oxidatively modified low density lipoprotein.
Valentinova NV; Gu ZW; Yang M; Yanushevskaya EV; Antonov IV; Guyton JR; Smith CV; Gotto AM; Yang CY
Biol Chem Hoppe Seyler; 1994 Oct; 375(10):651-8. PubMed ID: 7534086
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of oxidized phosphatidylcholines formed in oxidized low density lipoprotein by lecithin-cholesterol acyltransferase.
Itabe H; Hosoya R; Karasawa K; Jimi S; Saku K; Takebayashi S; Imanaka T; Takano T
J Biochem; 1999 Jul; 126(1):153-61. PubMed ID: 10393333
[TBL] [Abstract][Full Text] [Related]
14. Immunoreactivity of apo B towards monoclonal antibodies that inhibit the LDL-receptor interaction: effects of LDL oxidation.
Negri S; Roma P; Fogliatto R; Uboldi P; Marcovina S; Catapano AL
Atherosclerosis; 1993 Jun; 101(1):37-41. PubMed ID: 7692863
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical distribution of lipoprotein epitopes in xanthomata from patients with familial hypercholesterolemia.
Sugiyama N; Marcovina S; Gown AM; Seftel H; Joffe B; Chait A
Am J Pathol; 1992 Jul; 141(1):99-106. PubMed ID: 1378698
[TBL] [Abstract][Full Text] [Related]
16. Phospholipids in oxidized LDL not adducted to apoB are recognized by the CD36 scavenger receptor.
Podrez EA; Hoppe G; O'Neil J; Hoff HF
Free Radic Biol Med; 2003 Feb; 34(3):356-64. PubMed ID: 12543251
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins.
Radulescu L; Stancu C; Antohe F
Med Sci Monit; 2004 Jul; 10(7):BR207-14. PubMed ID: 15232494
[TBL] [Abstract][Full Text] [Related]
18. Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation.
Steinbrecher UP; Lougheed M; Kwan WC; Dirks M
J Biol Chem; 1989 Sep; 264(26):15216-23. PubMed ID: 2768257
[TBL] [Abstract][Full Text] [Related]
19. The preparation of copper-oxidized LDL for the measurement of oxidized LDL antibodies by EIA.
Lopes-Virella MF; Koskinen S; Mironova M; Horne D; Klein R; Chassereau C; Enockson C; Virella G
Atherosclerosis; 2000 Sep; 152(1):107-15. PubMed ID: 10996345
[TBL] [Abstract][Full Text] [Related]
20. Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects.
Shoji T; Nishizawa Y; Fukumoto M; Shimamura K; Kimura J; Kanda H; Emoto M; Kawagishi T; Morii H
Atherosclerosis; 2000 Jan; 148(1):171-7. PubMed ID: 10580183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
